Search
Close this search box.

EyePoint names Ribeiro CMO

ARTICLE | Management Tracks

Plus: Ford joins Prothena and updates from Atlas, Osmol and CytoVale

By Richard Guy, Biopharma Analyst, and Gunjan Ohri, Data Content Analyst 

March 6, 2024 1:05 AM UTC

EyePoint Pharmaceuticals Inc. (NASDAQ:EYPT) hired Ramiro Ribeiro to succeed CMO Dario Paggiarino, who has served in the role since 2016. Ribeiro was most recently VP, head of clinical development at Apellis Pharmaceuticals Inc. (NASDAQ:APLS). EyePoint also said it plans to report top-line data from its Phase II trial of tyrosine kinase inhibitor EYP-1901 to treat non-proliferative diabetic retinopathy in 2Q24.

Protein dysregulation company Prothena Corp. plc (NASDAQ:PRTA) hired David Ford as chief people officer, a newly created position. Ford was chief human resources officer at Intercept Pharmaceuticals Inc., before which he was at Sanofi (Euronext:SAN; NASDAQ:SNY)…